Intrinsic Value of S&P & Nasdaq Contact Us

Merck & Co., Inc. MRK NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
83/100
7/7 Pass
SharesGrow Intrinsic Value
$187.77
+56.5%
Analyst Price Target
$128.54
+7.2%

Stock Statistics — MRK

Merck & Co., Inc. (MRK) has a market capitalization of $296.59B and trades at $119.96. The 52-week range is 73.31-125.14.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 16.5, Earnings Per Share (EPS) of $7.28, annual revenue of $65.01B.

The stock has a beta of 0.28, a last dividend of $3.3200, operates in the Healthcare sector.

Trading Data
Current Price$119.96
52-Week Range73.31-125.14
Volume8.36M
Avg Volume (30D)11.35M
Market Cap$296.59B
Beta (1Y)0.28
Last Dividend$3.3200
Company
IPO Date1978-01-13
Employees73,000
CEORobert Davis
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS58933Y1055
CUSIP58933Y105
Income (Latest Year)
Revenue$65.01B
Gross Profit$52.98B
EBITDA$25.36B
Operating Income$26.78B
Net Income$18.25B
EPS$7.28
EPS Diluted$7.28
Shares Outstanding$2.51B
Balance Sheet (Latest Year)
Total Assets$136.87B
Current Assets$43.52B
Cash & ST Investments$14.57B
Total Liabilities$84.2B
Total Debt$50.53B
Net Debt$35.97B
Total Equity$52.66B
Debt / Equity0.96
Valuation Ratios
P/E Ratio16.5
P/S Ratio4.56
P/B Ratio5.63
EV/EBITDA (approx)11.7
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message